Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3 vs 6 Months Initial Steroid Treatment in Young Children With Steroid‑Sensitive Nephrotic Syndrome
ChiCTR2000037663Phase 4Recruiting
- Sponsor
- Children's Hospital of Fudan University
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisolone in nephrosis (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: Occurrence of frequent relapses of nephrotic syndrome at 12th month after 3 month standard treatment. Started Oct 2020; status: recruiting.
02
Drugs
prednisolone
03
Conditions
nephrosis
Beyond the preview
Go deeper on ChiCTR2000037663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037663.